ASX dips with Trump’s tariffs and China stimulus in the mix, miners ease the pain but insurance stocks keep getting smashed.
Clarity Pharmaceuticals will move to the next stage of its phase II trial to test its isotope-based therapy on prostate ...
The ASX has slipped (again) as the trade war chaos unfolds. WiseTech is scrambling to fill director spots and Virgin has a ...
Our retirement savings system is low-tax and among the world’s best, but sometimes it should be shunned. Here’s why.
Litchfield's IP survey has found a large system at its Oonagalabi project in the NT that will be tested in upcoming drilling.
Gold nabbed another month-end high, even if it failed to break its US$3000/oz ceiling, with rare earths and copper also on ...
James Bay Minerals’ (ASX:JBY) maiden resource at Independence is just the beginning with further drilling expected to deliver ...
The crypto market has experienced significant volatility over recent years with sentiment fluctuating between highs and lows.
Gold stocks soared last month, with a host of precious metals hunters surging over 100% as prices hit record levels.
These companies are positioned to capture expected demand growth in high purity alumina, or HPA, which has a range of ...
ASX fell after Trump’s tariffs spooked the market, with Canada and China firing back while Suncorp, Insignia and HCW got ...
EcoGraf posts strongest gains in over four years following the grant of a Special Mining Licence at the Epanko graphite ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results